IndraLab

Statements


STAMBPL1 activates Liu et al., 2022. 1 / 1
| 1

reach
"Our previous research revealed that STAMBPL1, a deubiquitinase, promotes cisplatin resistance in TNBC by stabilizing MKP1 (Liu et al., 2022)."